UA.V.E.K3: Prescription and over-the-counter medication.
ACS Area V — Operations Task E: Physiology References: AC 107-2; FAA-H-8083-2, FAA-H-8083-25; FAA-G-8082-22
Key Concepts
Effects of Medications on Remote Pilot Performance
A safe remote pilot requires full cognitive and physical capability. Medications—both prescription and over-the-counter—can significantly impair judgment, reaction time, coordination, and alertness, all of which are critical for the safe operation of a small unmanned aircraft system (sUAS). Even seemingly harmless over-the-counter drugs, such as antihistamines or cold medicines, can induce side effects like drowsiness or delayed reaction time, increasing the likelihood of errors and compromising operational safety.
Before conducting any sUAS operation, a remote pilot in command must carefully consider the potential effects of any medications they are taking. Medications can produce variable reactions due to factors such as dosage, time since ingestion, individual physiology, or interactions with other drugs or substances such as alcohol. Even if a drug is intended to improve health, its side effects may be hazardous in a flight environment[7].
Medical Fitness and Responsibility
The Federal Aviation Regulations hold the remote pilot in command responsible for assessing their own fitness to operate a UAS safely, which includes being free from the impairing effects of medications. Impairment—whether due to prescription or non-prescription medications—jeopardizes operational safety and is a critical concern for the FAA[7]. Remote pilots must ensure they are not under the influence of any substance that could diminish their ability to make sound decisions or operate the sUAS in accordance with all rules and safety protocols.
This responsibility extends to understanding that side effects may not always be immediately apparent. For example, drugs taken the night before a planned flight may still be present in the body and able to produce residual effects such as drowsiness, confusion, or slowed reaction times. This is particularly relevant for medications with long half-lives, which can remain in the system and continue to affect performance well beyond their primary period of intended action.
Practical Implications for Part 107 Remote Pilots
For successful compliance and safe operational practices under Part 107, remote pilots should adopt a conservative approach regarding medication use. If there is uncertainty about a medication’s impact, the best course is to postpone the sUAS operation until the pilot is confident there are no impairing effects[7].
Key action points for remote pilots include:
- Review All Medications: Consult with a healthcare provider about the effects of all prescribed and over-the-counter medications, and clarify if they are compatible with activities requiring alertness and coordination.
- Heed Warning Labels: Many medications include warnings about operating vehicles or heavy machinery; such cautions directly apply to the remote operation of sUAS.
- Monitor for Side Effects: Be vigilant for side effects such as dizziness, blurred vision, or cognitive slowing, especially when starting a new medication or a new dosage.
- Consider Interactions: Be aware that even substances like alcohol can enhance medication side effects, further degrading performance[7].
By proactively addressing the potential physiological impacts of medications, remote pilots uphold their regulatory and ethical duty to maintain safety during all operations, reducing the risk of accidents attributable to impaired performance. Proper self-assessment and caution are essential for maintaining the highest standards of safety in UAS operations.
Test Yourself
UA.V.E.K3No practice questions are currently available for this specific knowledge element.